Go Pro

Minerva Surgical (UTRS) Competitors

Minerva Surgical logo

UTRS vs. AFIB, MOTS, DRTSW, ANZUW, and HSCSW

Should you buy Minerva Surgical stock or one of its competitors? MarketBeat compares Minerva Surgical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Minerva Surgical include Acutus Medical (AFIB), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry.

How does Minerva Surgical compare to Acutus Medical?

Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

56.9% of Acutus Medical shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Acutus Medical Neutral

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Minerva Surgical has a beta of 2.92, suggesting that its stock price is 192% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, suggesting that its stock price is 467% more volatile than the broader market.

Minerva Surgical has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Minerva Surgical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

Motus GI has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, meaning that its share price is 192% more volatile than the broader market.

Motus GI has higher earnings, but lower revenue than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Minerva Surgical N/A N/A N/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Minerva Surgical compare to Alpha Tau Medical?

Minerva Surgical (NASDAQ:UTRS) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Alpha Tau Medical has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Alpha Tau Medical Neutral

Summary

Minerva Surgical beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does Minerva Surgical compare to Anzu Special Acquisition Corp I?

Anzu Special Acquisition Corp I (NASDAQ:ANZUW) and Minerva Surgical (NASDAQ:UTRS) are both medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Anzu Special Acquisition Corp I has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

Company Net Margins Return on Equity Return on Assets
Anzu Special Acquisition Corp IN/A N/A N/A
Minerva Surgical N/A N/A N/A

In the previous week, Anzu Special Acquisition Corp I's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Anzu Special Acquisition Corp I Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats Anzu Special Acquisition Corp I on 1 of the 1 factors compared between the two stocks.

How does Minerva Surgical compare to Heart Test Laboratories?

Minerva Surgical (NASDAQ:UTRS) and Heart Test Laboratories (NASDAQ:HSCSW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Heart Test Laboratories N/A N/A N/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Heart Test Laboratories Neutral

Heart Test Laboratories has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Heart Test Laboratories$8.67KN/AN/AN/AN/A

Summary

Minerva Surgical beats Heart Test Laboratories on 1 of the 1 factors compared between the two stocks.

Get Minerva Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTRS vs. The Competition

MetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$46.05M$7.16B$12.48B
Dividend YieldN/A1.08%2.66%6.52%
P/E Ratio0.0020.7528.0224.70
Price / SalesN/A31.08540.3799.49
Price / CashN/A18.8649.2657.09
Price / BookN/A8.4610.966.46
Net Income-$34.11M-$20.01M$3.57B$337.01M

Minerva Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$2.15
+2.4%
N/A+1,322.1%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.05
+52.0%
N/A+18.2%$0.00N/AN/A2

Related Companies and Tools


This page (NASDAQ:UTRS) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners